SEC Form 4 · accession 0001437749-18-017683
Sun BioPharma, Inc. · SNBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Robert Schemel
Director · 10% Owner
Period of report
Sep 27, 2018
Accepted (ET)
Oct 1, 2018 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $5.00 | Sep 27, 2018 | G | 11,767 | A | May 16, 2018 | May 16, 2021 | Common Stock | 11,767 | 11,767 | D |